This report studied the global biosurgery market during the forecast period of 2016 to 2021. The global biosurgery products market is expected to grow at a CAGR of 8.8% during the forecast period, to reach USD 27.78 Billion by 2021.
- Advertising -
The report "Biosurgery Market by Product (Fibrin & Collagen Sealant, Hemostats, Adhesion Barriers, Biological Meshs, Soft Tissue Attachments, Stapler, Bone Graft Substitues) Application (Orthopedic, Gynecology, Cardiovascular, Reconstructive) - Forecast to 2021", analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.
Growth in this market is attributed to factors such as rising number of surgeries, rising incidences of sports related injuries & spinal problems, rising need of effective blood loss management, and increasing clearance of biosurgery products by regulatory authorities.
- Advertising -
The global biosurgery market is segmented by product type, application, and geography. This report also discusses the key drivers, restraints, opportunities, and challenges for this market.
On the basis of product type, the market is primarily segmented into surgical sealants, hemostatic agents, adhesion barriers, bone graft substitutes, and staple line reinforcement agents. The surgical sealants market is sub-segmented into natural and synthetic/semi-synthetic sealants.
The bone graft substitutes market on the other hand is sub-segmented into bone-allografts, demineralized bone matrix, bone morphogenetic proteins, and synthetic bone-grafts. On the basis of application, the market is sub-segmented into cardiovascular surgeries, general surgeries, neurological surgeries, orthopaedic surgeries, thoracic surgeries, gynaecological surgeries, urology surgeries, and reconstructive surgeries.
For More Information, Request Brochure: www.marketsandmarkets.com/pdfdownload.asp?id=166922302
In 2015, the soft tissue attachments segment accounted for the largest share of the global biosurgery products market. This is majorly attributed to the rampant use of soft tissue patches across different types of surgeries.
This segment will continue to dominate the biosurgery products market by 2021, majorly due to the rising demand of these products from emerging countries and widening applications of soft tissue repair products across surgical procedures.
On the basis of region, the biosurgery market is broadly segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Presence of large number of market players, well-developed healthcare system, and presence of large number of hospitals in North America have boosted the growth of the biosurgery market in this region.
However, Asia-Pacific region is expected to grow at the highest CAGR, owing to rising health awareness, growth in per capita income, and improving healthcare infrastructure in this region.
Some of the major players operating in the global biosurgery market include C.R. Bard, Inc. (U.S.), Johnson & Johnson (U.S.), Baxter International Inc.
(U.S.), Covidien plc. (Ireland), Getinge Group (Sweden), B. Braun Melsungen AG (Germany), Cryolife Inc.
(U.S.), Stryker Corporation (U.S.), Hemostasis, LLC. (U.S.), and Sanofi Group (France).
Category: Market Research Publishers and RetailersCompany profile: MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth ...
For more information: